✨ Medicines Consent Notices




15 SEPTEMBER 2011

NEW ZEALAND GAZETTE, No. 141

4075

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Apo-Anastrozole
Active Ingredient: Anastrozole 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada

Product: Cimzia
Active Ingredient: Certolizumab pegol 200mg
Dosage Form: Solution for injection
New Zealand Sponsor: CSL Biotherapies (NZ) Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany

Product: Implanon NXT
Active Ingredient: Etonogestrel 68mg
Dosage Form: Subcutaneous implant
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: NV Organon, Oss, The Netherlands

Product: Lamivudine Alphapharm
Active Ingredient: Lamivudine 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Matrix Laboratories Limited, Nashik, India

Product: Next Choice
Active Ingredient: Levonorgestrel 0.75mg
Dosage Form: Tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Watson Laboratories Inc, California, United States of America

Dated this 8th day of September 2011.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go6345

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Lucentis
Active Ingredient: Ranibizumab 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland

Product: Xolair
Active Ingredient: Omalizumab 150mg
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma Stein AG, Stein, Switzerland
Genentech Inc, California, United States of America



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 141





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
8 September 2011
Medicines, Distribution, Consent, New Medicines, Apo-Anastrozole, Cimzia, Implanon NXT, Lamivudine Alphapharm, Next Choice
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines (Referred under Section 24(5))

πŸ₯ Health & Social Welfare
8 September 2011
Medicines, Distribution, Consent, New Medicines, Lucentis, Xolair
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health